Clinical trial NCT04091789 - References

Fatigue — Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea

Citation(s)

•   Baker FC, Driver HS, Rogers GG, Paiker J, Mitchell D
  High nocturnal body temperatures and disturbed sleep in women with primary dysmenorrhea. Am J Physiol. 1999 Dec;277(6):E1013-21. doi: 10.1152/ajpendo.1999.277.6.E1013.
•   Chantler I, Mitchell D, Fuller A
  Actigraphy quantifies reduced voluntary physical activity in women with primary dysmenorrhea. J Pain. 2009 Jan;10(1):38-46. doi: 10.1016/j.jpain.2008.07.002. Epub 2008 Aug 23.
•   Dorn LD, Negriff S, Huang B, Pabst S, Hillman J, Braverman P, Susman EJ
  Menstrual symptoms in adolescent girls: association with smoking, depressive symptoms, and anxiety. J Adolesc Health. 2009 Mar;44(3):237-43. doi: 10.1016/j.jadohealth.2008.07.018. Epub 2008 Oct 29.
•   Harel Z
  Dysmenorrhea in adolescents and young adults: etiology and management. J Pediatr Adolesc Gynecol. 2006 Dec;19(6):363-71. Review.
•   Iacovides S, Avidon I, Bentley A, Baker FC
  Reduced quality of life when experiencing menstrual pain in women with primary dysmenorrhea. Acta Obstet Gynecol Scand. 2014 Feb;93(2):213-7. doi: 10.1111/aogs.12287. Epub 2013 Nov 25.
•   Jamieson DJ, Steege JF
  The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol. 1996 Jan;87(1):55-8.
•   Latthe P, Latthe M, Say L, Gülmezoglu M, Khan KS
  WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health. 2006 Jul 6;6:177. Review.
•   Latthe P, Mignini L, Gray R, Hills R, Khan K
  Factors predisposing women to chronic pelvic pain: systematic review. BMJ. 2006 Apr 1;332(7544):749-55. Epub 2006 Feb 16. Review.
•   Latthe PM, Champaneria R
  Dysmenorrhoea. BMJ Clin Evid. 2014 Oct 21;2014. pii: 0813. Review.
•   Lefebvre G, Pinsonneault O, Antao V, Black A, Burnett M, Feldman K, Lea R, Robert M; SOGC
  Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can. 2005 Dec;27(12):1117-46. English, French.
•   Marjoribanks J, Proctor M, Farquhar C, Derks RS
  Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD001751. doi: 10.1002/14651858.CD001751.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;7:CD001751.
•   Proctor M, Farquhar C
  Diagnosis and management of dysmenorrhoea. BMJ. 2006 May 13;332(7550):1134-8. Review.
•   Stegeman BH, de Bastos M, Rosendaal FR, van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM
  Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ. 2013 Sep 12;347:f5298. doi: 10.1136/bmj.f5298. Review.
•   Wang T, Collet JP, Shapiro S, Ware MA
  Adverse effects of medical cannabinoids: a systematic review. CMAJ. 2008 Jun 17;178(13):1669-78. doi: 10.1503/cmaj.071178. Review.
•   Zannoni L, Giorgi M, Spagnolo E, Montanari G, Villa G, Seracchioli R
  Dysmenorrhea, absenteeism from school, and symptoms suspicious for endometriosis in adolescents. J Pediatr Adolesc Gynecol. 2014 Oct;27(5):258-65. doi: 10.1016/j.jpag.2013.11.008. Epub 2014 Apr 18.

A Controlled-Dose Study Using Cannabinoid Combinations in a Rapidly Dissolvable Sublingual Tablet for the Treatment of Dysmenorrhea and Associated Pain Symptoms

Details for clinical trial NCT04091789